[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370151-105":59,"doc-detail-370151-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","dosesdetails-for-the-cardiac-arrest-algorithms","Doses/Details for the Cardiac Arrest Algorithms","","Quick-reference clinical guidance for advanced cardiac life support, focusing on cardiac arrest management doses and algorithm steps. Covers CPR quality priorities including compression rate/depth, minimizing interruptions, avoiding excessive ventilation, and using quantitative waveform capnography and intra-arterial pressure when available. Provides ROSC monitoring indicators, defibrillation shock energy recommendations for biphasic and monophasic devices, reversible causes, and standard drug therapy dosing for epinephrine and antiarrhythmics. Includes STEMI fibrinolytic checklists and contraindications, plus a suspected stroke algorithm using the Cincinnati Prehospital Stroke Scale.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dosesdetails-for-the-cardiac-arrest-algorithms/370151/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dosesdetails-for-the-cardiac-arrest-algorithms/370151.png","ImageObject",300,407,{"name":92,"@type":93},"Rizky","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How should CPR quality be managed in the cardiac arrest algorithm?","Question",{"text":113,"@type":114},"Push hard (at least 5 cm) and fast (100-120/min), allow complete chest recoil, minimize interruptions, avoid excessive ventilation, and change the compressor every 2 minutes. If PETCO₂ is very low or intra-arterial relaxation pressure is reduced, attempt to improve CPR quality.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What defibrillation shock energies are recommended?",{"text":118,"@type":114},"For biphasic defibrillation, use the manufacturer’s recommendation (e.g., an initial 120-200 J); if unknown, use the maximum available. For monophasic, use 360 J, and give higher doses for subsequent shocks when appropriate.",{"name":120,"@type":111,"acceptedAnswer":121},"What are the absolute contraindications to fibrinolytic therapy in STEMI?",{"text":122,"@type":114},"Absolute contraindications include any prior intracranial hemorrhage, known malignant intracranial neoplasm, ischemic stroke within 3 months (with an exception for acute ischemic stroke within 3 hours), suspected aortic dissection, active bleeding or bleeding diathesis, and significant closed head/face trauma within 3 months.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370151,1790516145,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","# Doses/Details for the Cardiac Arrest Algorithms\n\nCardiac Arrest Algortm-2018 Updat  \n| CPR Quality   | Advanced Airway   |\n| --- | --- |\n| ·Push hard (at least 5 cm [2 inches])  \u003Cbr>and fast(100-120/min)and allow  \u003Cbr>complete chest recol.  \u003Cbr>·Minimize interruptions in  \u003Cbr>compressions.  \u003Cbr>·Avoid excessive ventilation.  \u003Cbr>·Change compressor every 2 minutes,  \u003Cbr>or sooner if facigued.  \u003Cbr>● If no advanced airway,30:2  \u003Cbr>compression-ventilation ratio.  \u003Cbr>·Quantitative waveform capnography  \u003Cbr>-If PETCO₂\u003C10 mm Hg,attempt  \u003Cbr>to improve CPR quality.  \u003Cbr>·Intra-arterial pressure  \u003Cbr>-If relaxation phase(diastolic)  \u003Cbr>pressure \u003C20 mm Hg,attempt  \u003Cbr>to improve CPR quality.   | ·Endotracheal intubation or  \u003Cbr>supraglottic advanced airway  \u003Cbr>·Waveform capnography or  \u003Cbr>capnometry to confirm and  \u003Cbr>monitor ET tube placement  \u003Cbr>·Once advanced airway in place,  \u003Cbr>give 1 breath every 6 seconds  \u003Cbr>(10 breaths/min)with continuous  \u003Cbr>chest compressions   |\n|  | Return of Spontaneous  \u003Cbr>Circulation (ROSC)   |\n|  | ·Pulse and blood pressure  \u003Cbr>·Abrupt sustained increase in  \u003Cbr>PETCO₂(typically ≥40 mm Hg)  \u003Cbr>·Spontaneous arterial pressure  \u003Cbr>waves with intra-arterial  \u003Cbr>monitoring   |\n| Shock Energy for Defibrillation   |  |\n| ·Biphasic:Manufacturer  \u003Cbr>recommendation (e.g.,initial  \u003Cbr>dose of 120-200 J);if unknown,  \u003Cbr>use maximum available,  \u003Cbr>Second and subsequent doses  \u003Cbr>should be equivalent,and  \u003Cbr>higher doses may be considered.  \u003Cbr>·Monophasic:360J   |  |\n|  | Reversible Causes   |\n|  | ·Hypovolemia  \u003Cbr>·Hypoxia  \u003Cbr>·Hydrogen ion(acidosis)  \u003Cbr>·Hypo-/hyperkalemia  \u003Cbr>·Hypothermia  \u003Cbr>·Tension pneumothorax  \u003Cbr>·Tamponade,cardiac  \u003Cbr>·Toxins  \u003Cbr>·Thrombosis,pulmonary  \u003Cbr>·Thrombosis,coronary   |\n| Drug Therapy   |  |\n| ·EpinephrineIV/IO dose:  \u003Cbr>1 mg every 3-5 minutes  \u003Cbr>·Amiodarone IV/IO dose:  \u003Cbr>First dose:300 mg bolus.  \u003Cbr>Second dose:150 mg.  \u003Cbr>-OR-  \u003Cbr>·Lidocaine IV/IO dose:  \u003Cbr>First dose:1-1.5 mg/kg.  \u003Cbr>Second dose 0.5-0.75 mg/kg.   |  |\n|  |  |\n\nACLS  \nCardiac Arrest Circular Algorithm-2018 Update  \nArrhythmias,andTheir Treatment  \nFibrinolytic Checklist for STEMIStep 1Step 2  \nSystolic BP>180 to 200 mmHg or diastolic BP>100 to 110 mm HgO YESONORight vs let arm systolic BP difference >15mm HgO YESHistory of structural central nervous system diseaseO YESO NO  \nSignificant closed head/facial traurna within the previous 3 monthsO YESO NOStroke>3 hours or\u003C3 monthsO YESO NORecent(within 2-4 weeks)major trauma,surgery (including laser eyesurgery),GI/GU bleedO YESAny history of intracranial hemorrhageO YESBleeding,clotting problem,or blood thinnersO YESPregnant femaleO YESO NOSerious systemic disease (e.g,advanced cancer,severe liver or kidney disease)O NO  \nIs patient at high risk?  \nIf ANY one of the following is checked YES,  \nStep 3  \nconsider transfer to PCl facility.  \nHeart rate 2100/min AND systolic BP\u003C100 mm HgOYES ONOPulmonary edema (rales)OYES ONOSigns of shock (cool,clammy)O YES O NOContraindications to fibrinolytic therapyOYESt ONORequired CPROYES O NO  \nContraindcations for fibinotytic use in STEMI areviewed as advisory forclinical decislon making and may not be allinclusiveor defnitive.These convaindlcationsare consistent with the 2004 ACCIAHA Guidelines for the Managemient of Patents WithST-Eevabon Myocardlal nlarction.  \nConslder transport to prinary PC facity as destlnation hospital.  \n## Contraindications for fibrinolytic use in STEMI consistent withACC/AHA 2007 Focused Update\n\n### Absolute Contraindications\n\n·Any prior intracranial hemorrhage  \n·Known structural cerebral vascular lesion (e.g.,arteriovenousmalformation)  \n·Known malignant intracranial neoplasm(primary ormetastatic)  \n·Ischemic stroke within 3 months EXCEPT acute ischemicstroke within 3 hours  \n·Suspected aortic dissection  \n·Active bleeding or bleeding diathesis(excluding menses)  \n·Significant closed head trauma or facial trauma within 3months  \n### Relative Contraindication","cbCaivjLaJpNWfzl","https://ap.wps.com/l/cbCaivjLaJpNWfzl","pdf",2538020,12,"English","# Doses/Details for the Cardiac Arrest Algorithms\n## CPR Quality and Advanced Airway\n## Return of Spontaneous Circulation (ROSC)\n## Shock Energy for Defibrillation\n## Reversible Causes\n## Drug Therapy\n## Contraindications for Fibrinolytic Use in STEMI (ACC/AHA 2007)\n### Absolute Contraindications\n### Relative Contraindications\n## Suspected Stroke Algorithm\n### Cincinnati Prehospital Stroke Scale","[{\"question\":\"How should CPR quality be managed in the cardiac arrest algorithm?\",\"answer\":\"Push hard (at least 5 cm) and fast (100-120/min), allow complete chest recoil, minimize interruptions, avoid excessive ventilation, and change the compressor every 2 minutes. If PETCO₂ is very low or intra-arterial relaxation pressure is reduced, attempt to improve CPR quality.\"},{\"question\":\"What defibrillation shock energies are recommended?\",\"answer\":\"For biphasic defibrillation, use the manufacturer’s recommendation (e.g., an initial 120-200 J); if unknown, use the maximum available. For monophasic, use 360 J, and give higher doses for subsequent shocks when appropriate.\"},{\"question\":\"What are the absolute contraindications to fibrinolytic therapy in STEMI?\",\"answer\":\"Absolute contraindications include any prior intracranial hemorrhage, known malignant intracranial neoplasm, ischemic stroke within 3 months (with an exception for acute ischemic stroke within 3 hours), suspected aortic dissection, active bleeding or bleeding diathesis, and significant closed head/face trauma within 3 months.\"}]","Doses/Details for the Cardiac Arrest Algorithms | PDF",1790187085]